| |
|
HE | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| 1. | North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension |
| |
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36.doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.
Justin R Boike 1, Bartley G Thornburg 2, Sumeet K Asrani 3, Michael B Fallon 4, Brett E Fortune 5, Manhal J Izzy 6, Elizabeth C Verna 7, Juan G Abraldes 8, Andrew S Allegretti 9, Jasmohan S Bajaj 10, Scott W Biggins 11, Michael D Darcy 12, Maryjane A Farr 13, Khashayar Farsad 14, Guadalupe Garcia-Tsao 15, Shelley A Hall 16, Caroline C Jadlowiec 17, Michael J Krowka 18, Jeanne Laberge 19, Edward W Lee 20, David C Mulligan 21, Mitra K Nadim 22, Patrick G Northup 23, Riad Salem 2, Joseph J Shatzel 24, Cathryn J Shaw 25, Douglas A Simonetto 26, Jonathan Susman 27, K Pallav Kolli 19, Lisa B VanWagner 28, Advancing Liver Therapeutic Approaches (ALTA) Consortium
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 8. | Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation |
| |
Am J Gastroenterol. 2022 Jul 11. doi: 10.14309/ajg.0000000000001901. Online ahead of print.
Ethan M Weinberg 1, Matthew Dukewich 2, Neha Jakhete 3, Elizabeth Stonesifer 3, Gene Y Im 4, Michael R Lucey 5, Kirti Shetty 3, John P Rice 5, David W Victor 3rd 6, Mark R Ghobrial 6, Akshay Shetty 6, Stephanie M Rutledge 7, Sander S Florman 4, Christine Hsu 8, Mohamed Shoreibah 9, Mahmoud Aryan 10, Babak J Orandi 11, Hyosun Han 12, Norah Terrault 12, Brian P Lee 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 17. | Hepatic encephalopathy |
| |
Nat Rev Dis Primers. 2022 Jun 23;8(1):43. doi: 10.1038/s41572-022-00366-6.
Dieter Häussinger 1, Radha K Dhiman 2, Vicente Felipo 3, Boris Görg 4, Rajiv Jalan 5 6, Gerald Kircheis 7, Manuela Merli 8, Sara Montagnese 9, Manuel Romero-Gomez 10, Alfons Schnitzler 11, Simon D Taylor-Robinson 12, Hendrik Vilstrup 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 25. | Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort |
| |
Clin Gastroenterol Hepatol. 2022 Apr 15;S1542-3565(22)00388-3.doi: 10.1016/j.cgh.2022.03.046. Online ahead of print.
Jasmohan S Bajaj 1, Puneeta Tandon 2, Jacqueline G O'Leary 3, K Rajender Reddy 4, Guadalupe Garcia-Tsao 5, Paul Thuluvath 6, Jennifer C Lai 7, Ram M Subramanian 8, Hugo E Vargas 9, Florence Wong 10, Andrew Fagan 11, Sara McGeorge 11, Leroy R Thacker 11, Patrick S Kamath 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 30. | Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis |
| |
Hepatol Commun. 2022 May;6(5):1113-1122. doi: 10.1002/hep4.1883. Epub 2022 Jan 14.
Simon Johannes Gairing 1 2, Julian Anders 1, Leonard Kaps 1 2, Michael Nagel 1 2, Maurice Michel 1 2, Wolfgang Maximilian Kremer 1 2, Max Hilscher 1 2, Peter Robert Galle 1 2, Jörn M Schattenberg 1 3, Marcus-Alexander Wörns 1 2 4, Christian Labenz 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 38. | Rifaximin-a reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial |
| |
J Hepatol. 2022 Feb;76(2):332-342.doi: 10.1016/j.jhep.2021.09.010. Epub 2021 Sep 24.
Vishal C Patel 1, Sunjae Lee 2, Mark J W McPhail 3, Kevin Da Silva 4, Susie Guilly 4, Ane Zamalloa 5, Elizabeth Witherden 6, Sidsel Støy 7, Godhev Kumar Manakkat Vijay 8, Nicolas Pons 4, Nathalie Galleron 4, Xaiohong Huang 8, Selin Gencer 9, Muireann Coen 9, Thomas Henry Tranah 10, Julia Alexis Wendon 10, Kenneth D Bruce 11, Emmanuelle Le Chatelier 4, Stanislav Dusko Ehrlich 4, Lindsey Ann Edwards 8, Saeed Shoaie 12, Debbie Lindsay Shawcross 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 63. | The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial |
| |
Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-0202. Online ahead of print.
Christophe Bureau 1, Dominique Thabut 2, Caroline Jezequel 3, Isabelle Archambeaud 4, Louis D'Alteroche 5, Sêbastien Dharancy 6, Patrick Borentain 7, Frédéric Oberti 8, Aurélie Plessier 9, Victor De Ledinghen 10, Nathalie Ganne-Carrié 11, Nicolas Carbonell 12, Vanessa Rousseau 13, Agnès Sommet 13, Jean Marie Péron 1, Jean Pierre Vinel 1
|
|
| |
|
|
| |
|
|
| |
| 66. | North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension |
| |
Clin Gastroenterol Hepatol. 2021 Jul 15;S1542-3565(21)00749-7.doi: 10.1016/j.cgh.2021.07.018. Online ahead of print.
Justin R Boike 1, Bartley G Thornburg 2, Sumeet K Asrani 3, Michael B Fallon 4, Brett E Fortune 5, Manhal J Izzy 6, Elizabeth C Verna 7, Juan G Abraldes 8, Andrew S Allegretti 9, Jasmohan S Bajaj 10, Scott W Biggins 11, Michael D Darcy 12, Maryjane A Farr 13, Khashayar Farsad 14, Guadalupe Garcia-Tsao 15, Shelley A Hall 16, Caroline C Jadlowiec 17, Michael J Krowka 18, Jeanne Laberge 19, Edward W Lee 20, David C Mulligan 21, Mitra K Nadim 22, Patrick G Northup 23, Riad Salem 2, Joseph J Shatzel 24, Cathryn J Shaw 25, Douglas A Simonetto 26, Jonathan Susman 27, K Pallav Kolli 19, Lisa B VanWagner 28, Advancing Liver Therapeutic Approaches (ALTA) Consortium
|
|
| |
|
|
| |
| 68. | Sleep and liver disease: a bidirectional relationship |
| |
Lancet Gastroenterol Hepatol. 2021 Jul 14;S2468-1253(21)00169-2.doi: 10.1016/S2468-1253(21)00169-2. Online ahead of print.
Thomas Marjot 1, David W Ray 2, Felicity R Williams 3, Jeremy W Tomlinson 2, Matthew J Armstrong 4
|
|
| |
|
|
| |
|
|
| |
| 71. | Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial) |
| |
BMJ Open Gastroenterol. 2020 Dec;7(1):e000531. doi: 10.1136/bmjgast-2020-000531.
K de Wit 1, J J Schaapman 2, F Nevens 3, J Verbeek 3, S Coenen 4, F J C Cuperus 5, M Kramer 6, E T T L Tjwa 7, N Mostafavi 8, M G W Dijkgraaf 9, O M van Delden 10, U H W Beuers 1, M J Coenraad 2, R B Takkenberg 11
|
|
| |
| 72. | The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis |
| |
J Hepatol. 2020 Dec 7;S0168-8278(20)33836-8. doi: 10.1016/j.jhep.2020.11.048.Online ahead of print.
Vicente Arroyo 1, Paolo Angeli 2, Richard Moreau 3, Rajiv Jalan 4, Joan Claria 5, Jonel Trebicka 6, Javier Fernández 5, Thierry Gustot 7, Paolo Caraceni 8, Mauro Bernardi 8, investigators from the EASL-CLIF Consortium, Grifols Chair; European Foundation for the Study of Chronic Liver Failure (EFClif)
|
|
| |
|
|
| |
| 74. | The use of Rifaximin in Patients with Cirrhosis |
| |
Hepatology. 2021 Jan 9. doi: 10.1002/hep.31708. Online ahead of print.
Paolo Caraceni 1, Victor Vargas 2, Elsa Solà 3, Carlo Alessandria 4, Koos de Wit 5, Jonel Trebicka 6 7, Paolo Angeli 8, Rajeshwar P Mookerjee 9, François Durand 10, Elisa Pose 3, Aleksander Krag 11 12, Jasmohan S Bajaj 13, Ulrich Beuers 5, Pere Ginès 3
|
|
| |
|
|
| |
|
| |
|
|
|
|
|
Stay Informed!
